Serology-Based Model for Personalized Epithelial Ovarian Cancer Risk Evaluation
This study aimed to establish a prognosis-prediction model based on serological indicators in patients with epithelial ovarian cancer (EOC). Patients initially diagnosed as ovarian cancer and surgically treated in Fudan University Shanghai Cancer Center from 2014 to 2018 were consecutively enrolled....
Main Authors: | Tianqing Yan, Xiaolu Ma, Haoyun Hu, Zhiyun Gong, Hui Zheng, Suhong Xie, Lin Guo, Renquan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/29/4/220 |
Similar Items
-
Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group
by: Grégoire Rocher, et al.
Published: (2021-03-01) -
The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma
by: Pan Q, et al.
Published: (2023-02-01) -
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
by: Nodin Björn, et al.
Published: (2012-09-01) -
High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer
by: Jinfeng Wang, et al.
Published: (2024-01-01) -
Folate receptor genes were up-regulated in epithelial ovarian cancer and partly associated with patients’ prognosis
by: Yang Juanli, et al.
Published: (2022-11-01)